LOGIN
Butorphanol as an Adjuvant to Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty
December 2022
Butorphanol as an Adjuvant to Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Butorphanol as an Adjuvant to Ropivacaine for Adductor Canal Blocks in Total Knee Arthroplasty Patients: A Randomized, Double, Blind Study
J Healthc Eng. 2022 Oct 14;2022:7718108.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy-four older patients (50-80 years) undergoing a first-time unilateral total knee arthroplasty were randomized to receive an adductor canal blockade with ropivacaine plus butorphanol as an adjuvant (n=37) or ropivacaine only (n=37). The primary outcome of interest was the duration of sensory block and Visual Analog Scale (VAS) pain scores at rest and with activity. Secondary outcomes of inte...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.